Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
Dafna Yahav(Sheba Medical Center), Elad Goldberg, Nesrin Ghanem‐Zoubi(Rambam Health Care Campus), Leonard Leibovici(Tel Aviv University), Erica Franceschini(University of Modena and Reggio Emilia), Hiba Zayyad(Bar-Ilan University), Noa Eliakim‐Raz(Tel Aviv University), Yonatan Edel(Tel Aviv University), Yaakov Dickstein(Tel Aviv Sourasky Medical Center), Danny Alon(Rabin Medical Center), Tanya Babich(Unknown), Ami Neuberger(Technion – Israel Institute of Technology), Mical Paul(Technion – Israel Institute of Technology), Claudia Venturelli(Azienda Ospedaliero-Universitaria di Modena), Anat Stern(Technion – Israel Institute of Technology), Elias Maroun(Rambam Health Care Campus), Cristina Mussini(University of Modena and Reggio Emilia), Adi Turjeman(Rabin Medical Center), Fidi Koppel(Rambam Health Care Campus), Jihad Bishara(Tel Aviv University), Roni Bitterman(Rambam Health Care Campus), Antonella Santoro(University of Modena and Reggio Emilia), Barak Pertzov(Tel Aviv University), Tali Steinmetz(Rabin Medical Center)
Cited by 424
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
|Clinical Microbiology and Infection|2021|1k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
|Antimicrobial Agents and Chemotherapy|2010|727